Gambro buys back Korean selling rights:
This article was originally published in Clinica
Executive Summary
Gambro, the Swedish-based renal care company, has acquired the sales rights in Korea for certain products from its COBE subsidiary, representing annual sales of $6 million. Seajin Medicare, which has 10 employees, will fold itself into Gambro Korea and its president, KS Chai, will become president of Gambro Korea. He succeeds Bo-Inge Hansson, who moves up to become president, Gambro Asia Pacific. The items concerned include COBE BCT blood component technology and renal care products.